APA (7th ed.) Citation

Mansfield, A. S., Rudek, M. A., Vulih, D., Smith, G. L., Harris, P. J., & Ivy, S. P. (2016). The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer Subjects. Clinical cancer research, 22(22), 5472-5479. https://doi.org/10.1158/1078-0432.CCR-16-0449

Chicago Style (17th ed.) Citation

Mansfield, Aaron S., Michelle A. Rudek, Diana Vulih, Gary L. Smith, Pamela Jo Harris, and S. Percy Ivy. "The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer Subjects." Clinical Cancer Research 22, no. 22 (2016): 5472-5479. https://doi.org/10.1158/1078-0432.CCR-16-0449.

MLA (9th ed.) Citation

Mansfield, Aaron S., et al. "The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer Subjects." Clinical Cancer Research, vol. 22, no. 22, 2016, pp. 5472-5479, https://doi.org/10.1158/1078-0432.CCR-16-0449.